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1. Introduction 
Receptor assay using labelled parathyrin (PTH) 
allowed so far only binding studies in the unphysiolo- 
gical/~g-range [1-3].  This is probably due to chemical 
and conformational changes of the labelled hormone 
with consequent rapid degradation atthe receptor 
site. Labelling of peptide hormones with the most 
commonly used isotope 12sj even under 'mild condi- 
tions' grossly alters the physicochemical state of the 
respective hormones. Receptor studies using ~2sj 
labelled hormones reflect a physicochemical behaviour 
of these hormones at the receptor site but not 
necessarily a physiological function inherent to the 
unlabelled hormone. We have described recently a
new method of a receptor assay using labelled anti- 
bodies instead of labelled hormone [4-7] with a 
true sensitivity of 1000-2000 fg of bovine (bPTH)/ 
100/~g renal plasma membrane protein. Herein we 
present data on characteristics of the PTH receptor 
using enzyme treatment. 
2. Materials and methods 
The labelled-antibody-membrane-assay (LAMA) 
was performed as described [4,5]. Antibody AVII-3 
(kindly provided by Dr. Bouillon. Rega Institute 
Leuven, Belgium) was labelled with 12sj after extrac- 
tion onto UG-bPTH-Immunoadsorbent (ImAd). 
UG-bPTH refers to bPTH (Sephadex G-75 purified 
bPTH from Hormon-Chemie, M/inchen) chromato- 
graphed on Ultrogel AcA 54 (LKB, Gr/ifelfing), 
column size 2.5 × 100 cm, to yield highly purified 
bPTH (1500-2000 U/mg). bPTH standard was the 
preparation 71/324 from the MRC, Mill Hill, London, 
exhibiting high biological activity [5]. In all studies 
with LAMA a constant concentration f bPTH 
(12.5 ng/ml) was used. Chick kidney plasma mem- 
branes (from 18-20 weeks old animals) were prepared 
following essentially the technique of Fitzpatrick et 
al. [8], membrane purity was controlled by electron 
microscopy and protein was estimated by a biuret- 
method (Boehringer, No. 15899). Membranes were 
stored at -60°C and were found to be stable (bPTH 
binding and preservation of adenylate cyclase activity) 
for at least 2 months. Bovine membranes were 
prepared from homogenates of freshly free dissected 
renal cortex at 4°C. Trypsin (Cat. No. 15330), 
phospholipase A (Cat. No. 15057), phospholipase D 
(Cat. No. 15345), Neuraminidase (Cat. No. 15434) 
and Galactosidase (Cat. No. 15079) were from 
Boehringer Mannheim. Duplicates of 150/ag renal 
plasma membrane protein were treated with different 
concentrations of the respective enzyme dissolved in 
Albano-buffer [4] as indicated. After incubation over 
40 min at 37°C membranes were washed twice in 
Albano-buffer [4] and LAMA perfoI,ned as described. 
For control membranes were incubated in buffer 
only before assay. Results are expressed as percentage 
increase of receptor bound hormone detected by 
labelled antibody over background (plasma membranes 
in the absence of bPTH standard addition with and 
without prior enzyme treatment) * SEM. Enzyme 
treated membranes did not alter background binding 
of labelled antibody apart from trypsii: due to 
protein denaturation, bPTH control binding in 
untreated membranes was set as 100% [4,5]. 
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3. Results and discussion 
Cuatrecasas has recently summarized studies on 
the enzymatic modification of insulin and glucagon 
receptors [9]. Such treatment indicates the impor- 
tance of distinct membrane constituents o bind 
hormones. Our results on enzyme treatment of 
bovine and ovine renal plasma membranes (Fig.l) 
suggest species related structural differences of the 
cell surface. Trypsin at low concentrations reduced 
and in higher concentrations abolished bPTH binding 
to both ovine and bovine membranes. This is in 
agreement with Chase who has recently reported on 
the selective proteolysis of the receptor for PTH 
whereas the receptor for calcitonin and prostaglandin 
Ea was not altered [10]. These results were, how- 
ever, derived from PTH mediated increase of 3,5'- 
cAMP in renal cortex in contrast to the direct effect 
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Fig.1. Effect of pretreating ovine (upper part of the figure) 
and bovine plasma membranes (lower part) with increasing 
concentrations of enzymes. 
on binding demonstrated by our results. Similar 
effects of trypsin have been noted on insulin and 
glucagon receptors. Phospholipase A in low con- 
centration of 1.0/~g/ml increased binding of bPTH 
to bovine membranes by 27% but much more to 
ovine membranes, by 80%. 10-50/lg/ml of phospho- 
lipase A diminished binding in bovine membranes 
drastrically, whereas in ovine membranes binding 
was still increased from 70-230% over control 
without prior enzyme treatment. The effect of 
phospholipase D treatment shows an essentially 
similar pattern to that of phospholipase A in mem- 
branes of both species. Therefore, the bovine 
receptor for bPTH bears a strong resemblance to
tire glucagon receptor in liver membranes whereas 
the ovine receptor for bPTH resembles the insulin 
receptor. Phospholipase treatment of ovine mem- 
branes exposes new bPTH binding sites which are 
probably freely exposed to the aqueous environment. 
In bovine membranes, however, phospholipids form 
an essential constituent of the receptor to maintain 
the binding conformation asemphazised recently for 
glucagon by Rubalcava nd Rodbell [ 11 ]. 
Galactosidase in concentrations from 10-50 
/ag/ml increases bPTH binding to ovine membranes, 
but higher doses had no effect, whereas in bovine 
membranes galactosidase treatment causes aprofound 
fall in hormone binding. Galactose groups and hence 
glycoproteins may be of crucial importance in the 
bovine bPTH receptor similar to the insulin receptor, 
but galactose seems only a minor constituent of the 
glycoprotein composition i  ovine membranes. 
Neuraminidase has only in the high concentrations 
of 200 ~g]ml a depressive effect of bPTH binding in 
bovine receptor indicating that gangliosides are not 
critical in the glycolipid structure. Again, a similarity 
to the insulin receptor isevident in contrast to ovine 
membranes where neuraminidase increases binding 
mainly at low concentrations. Our results clearly 
show that the structural requirement and the overall 
conformation of the bPTH receptor is quite different 
between ovine and bovine species. The glycoprotein 
nature of bovine receptor and the critical importance 
of phospholipids for bPTH binding are evident. This 
result may possibly be relevant in the interpretation 
of species differences described for the interaction 
of bPTH with receptor preparations from different 
species [12-14]. 
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